Ratanapunt Incharoensakdi

Spécialisation: Cardiologist
41 années d'expérience
Parle:
English, Thai
Consultations en ligne : disponibles
Espace de travail: Thaïlande, Bangkok, Centre médical Longa Heart Health
Avec plus de 40 ans d'expérience, le Dr Ratanapunt Incharoensakdi (Dr Inc) est l'un des cardiologues les plus éminents de Thaïlande, formé à l'international au Japon et en Allemagne, et un pionnier des traitements non invasifs des maladies cardiaques en Thaïlande. Il a fondé le centre cardiaque du Bangkok Hospital, le premier centre cardiaque spécialisé de Thaïlande, et a soigné avec succès des milliers de patients au Bangkok Hospital et au Bumrungrad International Hospital.
Le Dr Ratanapunt Incharoensakdi est un cardiologue pionnier au Longa Heart Health Medical Center. Il a fondé le premier centre cardiaque spécialisé de Thaïlande au Bangkok Hospital en 1988. Il est spécialisé dans les traitements non invasifs des maladies cardiaques et les thérapies régénératives par cellules souches. Le Dr Ratanapunt a soigné avec succès plus de 5 000 patients au cours de sa carrière.
- Formé en cardiologie à l'Université de Kyoto et à l'Université de Hambourg.
- A introduit la réadaptation cardiaque non invasive et la revitalisation holistique en Thaïlande.
- Traite des pathologies complexes telles que l'insuffisance cardiaque et la maladie coronarienne.
- Expert en thérapie par cellules souches pour les maladies cardiaques et l'hypertension pulmonaire.

Consultation en ligne avec Ratanapunt Incharoensakdi

Pratique et facile

100 % sécurisé et confidentiel

$150

Services du médecin

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Ratanapunt Incharoensakdi is a pioneer of non-invasive heart disease treatments in Thailand. He founded the Bangkok Heart Center. This facility served as the first specialized cardiac center in the country. He has performed 5,000+ operations. He also holds fellowships from Japan and Germany.

Specialization and Cardiac Approach

Dr. Incharoensakdi focuses on non-invasive cardiology and regenerative medicine. He uses stem cell therapy to treat heart failure and pulmonary hypertension. This technique uses specialized cells to repair damaged heart tissue. The specialist also treats coronary artery disease through interventionist techniques. His programs include cardiac rehabilitation and revitalization for long-term recovery.

The doctor treats a variety of complex cardiovascular conditions:

Coronary artery disease and atherosclerosis
Hypertension and pulmonary hypertension
Atrial fibrillation and other arrhythmias
Dilated cardiomyopathy
Post-myocardial infarction complications
Raynaud’s disease

Professional Achievements

Dr. Incharoensakdi established the first multidisciplinary cardiac programs in Thailand. He introduced non-invasive treatment protocols. These protocols reduced the need for open surgery. He has cared for thousands of patients at Thai hospitals. He currently leads the Longa Heart Health Medical Center in Bangkok.

Work Experience

Founder and Senior Cardiologist – Bangkok Heart Center, Bangkok Hospital (1988–Present)
Senior Cardiologist – Bangkok Hospital
Senior Cardiologist – Bumrungrad International Hospital
Founder – Longa Heart Health Medical Center (2023–Present)

Education and Training

Dr. Incharoensakdi completed his medical degree at Mahidol University in Thailand. He pursued international training to bring modern techniques to his home country. Finally, he holds two board certifications in Internal Medicine and Cardiology.

Degree in Medicine – Ramathibodi Hospital, Mahidol University, Thailand
1985 – Cardiology Fellowship – Kyoto University, Japan
1987 – Advanced Cardiology Training – University of Hamburg, Germany

Diagnostic Expertise

The doctor uses technology to assess heart health. He performs echocardiography and stress testing. He also conducts carotid artery ultrasounds and body composition analysis. Additionally, he provides specialized heart check-ups for men, women, and pediatric patients.